Mitochondrial metabolism and targeted treatment strategies in ischemic-induced acute kidney injury

Yongming Chen,Zixian Li,Hongyong Zhang,Huixia Chen,Junfeng Hao,Huafeng Liu,Xiaoyu Li

DOI: https://doi.org/10.1038/s41420-024-01843-5

2024-02-11

Cell Death Discovery

Abstract:Ischemia-reperfusion injury (IRI) is a common cause of acute kidney injury (AKI). The kidney is susceptible to IRI under several clinical conditions, including hypotension, sepsis, and surgical procedures, such as partial nephrectomy and kidney transplantation. Extensive research has been conducted on the mechanism and intervention strategies of renal IRI in past decades; however, the complex pathophysiology of IRI-induced AKI (IRI-AKI) is not fully understood, and there remains a lack of effective treatments for AKI. Renal IRI involves several processes, including reactive oxygen species (ROS) production, inflammation, and apoptosis. Mitochondria, the centers of energy metabolism, are increasingly recognized as substantial contributors to the early phases of IRI. Multiple mitochondrial lesions have been observed in the renal tubular epithelial cells (TECs) of IRI-AKI mice, and damaged or dysfunctional mitochondria are toxic to the cells because they produce ROS and release cell death factors, resulting in TEC apoptosis. In this review, we summarize the recent advances in the mitochondrial pathology in ischemic AKI and highlight promising therapeutic approaches targeting mitochondrial dysfunction to prevent or treat human ischemic AKI.

cell biology

What problem does this paper attempt to address?

This paper aims to explore the mechanisms by which Ischemia-Reperfusion Injury (IRI) leads to Acute Kidney Injury (AKI) and proposes potential therapeutic strategies targeting mitochondrial dysfunction. Specifically:

1. **Research Background**: IRI is a common cause of AKI, especially in clinical situations such as hypotension, sepsis, and partial nephrectomy. Despite extensive research on the mechanisms of IRI, the complex pathophysiology of IRI-induced AKI has not been fully elucidated, and effective treatments for AKI are currently lacking.

2. **Main Issues**: The kidneys exhibit severe mitochondrial damage under IRI conditions, including elevated levels of Reactive Oxygen Species (ROS) and reduced ATP production. Mitochondrial damage leads to cell apoptosis, thereby exacerbating kidney injury.

3. **Research Objectives**: This paper reviews recent advances in the study of mitochondrial pathology in ischemic AKI and highlights promising therapeutic approaches targeting mitochondrial dysfunction to prevent or treat human ischemic AKI. Through these studies, the authors hope to provide a theoretical basis and technical support for the development of new AKI treatment strategies.

In summary, this review paper aims to reveal the role of mitochondria in IRI-AKI and its potential therapeutic targets, with the goal of finding new treatments to improve the prognosis of AKI patients.